{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:50:25Z","timestamp":1794243025705,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heparin-Binding Protein (HBP) is a promising biomarker for predicting the severity of community-acquired pneumonia (CAP). This study aimed to evaluate its role in pediatric CAP severity assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective observational study was conducted at the Pediatric Intensive Care Unit (PICU)and general wards of Menoufia University Hospital from February 2024 to October 2024. Thirty children with mild pneumonia (Simple Pneumonia) and 60 with severe pneumonia admitted to the PICU (Severe Pneumonia) were enrolled. Severity was assessed using WHO criteria and several clinical scores: Pediatric Respiratory Severity Score(PRESS), Respiratory Index of Severity Score (RISC), modified Predisposition, Insult, Response, and Organ dysfunction(PIROm), Pediatric Risk of Mortality(PRISM), Pediatric Index of Mortality2 (PIM2), and pediatric Sequential Organ Failure Assessment (pSOFA). Serum HBP levels were measured upon admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean HBP levels were significantly higher in severe pneumonia compared with simple pneumonia [7.87\u2009ng\/mL vs 0.73\u2009ng\/mL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001]. All severity scores were also significantly elevated in this group and HBP was significantly correlated with these severity scores. In multivariate logistic regression, HBP was an independent predictor of pneumonia severity (adjusted odd ratio=3.23; 95%confidence interval: 1.72\u20136.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).HBP showed excellent predictive performance, with an area under the curve (AUC) of 0.962 for severe pneumonia. A cut-off &gt;1.2\u2009ng\/mL for HBP yielded 100% sensitivity and 90% specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum HBP is a reliable and highly accurate biomarker for assessing CAP severity in pediatric patients and may support early clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact statement<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Early Risk Stratification<\/jats:bold>\n                            : This study identifies Heparin-Binding Protein (HBP) as a powerful biomarker for early prediction of disease severity in pediatric community-acquired pneumonia, with an excellent diagnostic performance (AUC 0.962).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Clinical Utility<\/jats:bold>\n                            : HBP demonstrated 100% sensitivity and 90% specificity at a cut-off &gt;1.2\u2009ng\/mL, outperforming traditional clinical scores in distinguishing severe from mild cases, which can aid timely PICU admission decisions.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Potential for Practice Integration<\/jats:bold>\n                            : Incorporating HBP measurement into initial assessment protocols may enhance clinical decision-making, improve outcomes, and optimize resource allocation, especially in settings with high pediatric pneumonia burden.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Cost and Availability of Heparin-Binding Protein<\/jats:bold>\n                            : HBP levels were measured using a commercially available ELISA kit, as the test is not yet widely available in routine clinical laboratories. The assay cost ranges from approximately $400 to $800 per 96-well plate, with an estimated per-sample cost of $10\u201330. Due to the limited availability of clinical-grade HBP assays, testing was conducted under research conditions in a controlled laboratory setting.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04605-w","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:24:10Z","timestamp":1765455850000},"page":"387-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric community-acquired pneumonia: predictive value of heparin-binding protein for severity assessment"],"prefix":"10.1038","volume":"100","author":[{"given":"Nagwan Y.","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoria A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud F.","family":"Al Gady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania S. El-Deen","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"4605_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/PCC.0000000000002680","volume":"22","author":"R Samransamruajkit","year":"2021","unstructured":"Samransamruajkit, R. et al. Pediatric severe sepsis and shock in three Asian countries: a retrospective study of outcomes in nine PICUs. Pediatr. Crit. Care Med. 22, 713\u2013721 (2021).","journal-title":"Pediatr. Crit. Care Med."},{"key":"4605_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/PCC.0000000000003598","volume":"25","author":"JJM Wong","year":"2024","unstructured":"Wong, J. J. M. et al. Severe pneumonia in PICU admissions: the Pediatric Acute and Critical Care Medicine Asian Network (PACCMAN) observational cohort study, 2020\u20132022. Pediatr. Crit. Care Med. 25, 1035\u20131044 (2024).","journal-title":"Pediatr. Crit. Care Med."},{"key":"4605_CR3","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","volume":"7","author":"DA McAllister","year":"2019","unstructured":"McAllister, D. A. et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob. Health 7, e47\u2013e57 (2019).","journal-title":"Lancet Glob. Health"},{"key":"4605_CR4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","volume":"24","author":"GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect. Dis. 24, 974\u20131002 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"4605_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1515\/labmed-2023-0077","volume":"47","author":"C Li","year":"2023","unstructured":"Li, C. et al. Predictive value of combined serum IL-6 with urea on severity of neonatal pneumonia: an observational study. J. Lab. Med. 47, 251\u2013256 (2023).","journal-title":"J. Lab. Med."},{"key":"4605_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-016-0104-3","volume":"4","author":"P Bentzer","year":"2016","unstructured":"Bentzer, P. et al. Heparin-binding protein is important for vascular leak in sepsis. Intensive Care Med. Exp. 4, 33 (2016).","journal-title":"Intensive Care Med. Exp."},{"key":"4605_CR7","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1097\/CCM.0000000000004738","volume":"49","author":"YL Wu","year":"2021","unstructured":"Wu, Y. L. et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis. Crit. Care Med. 49, e80\u2013e90 (2021).","journal-title":"Crit. Care Med."},{"key":"4605_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2614-3","volume":"23","author":"B Liu","year":"2019","unstructured":"Liu, B., Chen, Y. X., Yin, Q., Zhao, Y. Z. & Li, C. S. Diagnostic value and prognostic evaluation of heparin-binding protein in sepsis: a systematic review and meta-analysis. Crit. Care 23, 336 (2019).","journal-title":"Crit. Care"},{"key":"4605_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07233-5","volume":"22","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. Diagnostic performance of heparin-binding protein in infection and sepsis: a systematic review and meta-analysis. BMC Infect. Dis. 22, 252 (2022).","journal-title":"BMC Infect. Dis."},{"key":"4605_CR10","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11056","volume":"9","author":"R Cai","year":"2021","unstructured":"Cai, R., Li, H. & Tao, Z. Heparin-binding protein and procalcitonin in the diagnosis of pathogens causing community-acquired pneumonia in adult patients: a retrospective study. PeerJ 9, e11056 (2021).","journal-title":"PeerJ"},{"key":"4605_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.759535","volume":"9","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. Heparin-binding protein in critically ill children with severe community-acquired pneumonia. Front Pediatr. 9, 759535 (2021).","journal-title":"Front Pediatr."},{"key":"4605_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6123911","volume":"2023","author":"C Huang","year":"2023","unstructured":"Huang, C., Mo, Y., Mo, L., Zhang, L. & Zhang, J. Heparin-binding protein in bronchoalveolar lavage fluid as a biomarker for discriminating severe bacterial and viral pneumonia in critically ill children. Mediators Inflamm. 2023, 6123911 (2023).","journal-title":"Mediators Inflamm."},{"key":"4605_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/JIR.S393600","volume":"16","author":"S Li","year":"2023","unstructured":"Li, S. et al. Heparin-binding protein: a prognostic biomarker associated with severe or complicated community-acquired pneumonia in children. J. Inflamm. Res 16, 321\u2013331 (2023).","journal-title":"J. Inflamm. Res"},{"key":"4605_CR14","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2011-200598","volume":"66","author":"M Harris","year":"2011","unstructured":"Harris, M. et al. British Thoracic Society guidelines for the management of community-acquired pneumonia in children: update 2011. Thorax 66, i1\u201323 (2011).","journal-title":"Thorax"},{"key":"4605_CR15","unstructured":"World Health Organization. Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries (WHO, 2014)."},{"key":"4605_CR16","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley, J. S. et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 53, e25\u2013e76 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"4605_CR17","first-page":"1009","volume":"2","author":"Y Miyaji","year":"2015","unstructured":"Miyaji, Y. et al. Pediatric respiratory severity score (PRESS) for respiratory tract infections in children. Austin Virol. Retrovirol. 2, 1009 (2015).","journal-title":"Austin Virol. Retrovirol."},{"key":"4605_CR18","doi-asserted-by":"publisher","first-page":"e27793","DOI":"10.1371\/journal.pone.0027793","volume":"7","author":"C Reed","year":"2012","unstructured":"Reed, C. et al. Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PLoS One 7, e27793 (2012).","journal-title":"PLoS One"},{"key":"4605_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/INF.0000000000001018","volume":"35","author":"S Araya","year":"2016","unstructured":"Araya, S. et al. Application of a prognostic scale to estimate the mortality of children hospitalized with community-acquired pneumonia. Pediatr. Infect. Dis. J. 35, 369\u2013373 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"4605_CR20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/00003246-198811000-00006","volume":"16","author":"MM Pollack","year":"1988","unstructured":"Pollack, M. M., Ruttimann, U. E. & Getson, P. R. Pediatric risk of mortality score. Crit. Care Med. 16, 1110\u20131116 (1988).","journal-title":"Crit. Care Med."},{"key":"4605_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00134-002-1601-2","volume":"29","author":"A Slater","year":"2003","unstructured":"Slater, A., Shann, F. & Pearson, G. PIM 2: a revised version of the Pediatric Index of Mortality. Intensive Care Med. 29, 278\u2013285 (2003).","journal-title":"Intensive Care Med."},{"key":"4605_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00134-017-5021-8","volume":"44","author":"LJ Schlapbach","year":"2018","unstructured":"Schlapbach, L. J., Straney, L., Bellomo, R., MacLaren, G. & Pilcher, D. Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit. Intensive Care Med. 44, 179\u2013188 (2018).","journal-title":"Intensive Care Med."},{"key":"4605_CR23","unstructured":"World Health Organization. Hypoxemia and hypoxia. In: Oxygen Therapy for Children: a Manual for Health Workers (WHO, 2016)."},{"key":"4605_CR24","doi-asserted-by":"crossref","first-page":"S876","DOI":"10.1161\/CIRCULATIONAHA.109.915165","volume":"122","author":"ME Kleinman","year":"2010","unstructured":"Kleinman, M. E. et al. 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: Pediatric Advanced Life Support. Circulation 122, S876\u2013S908 (2010).","journal-title":"Circulation"},{"key":"4605_CR25","doi-asserted-by":"publisher","first-page":"1037.e1","DOI":"10.1016\/j.cmi.2021.03.002","volume":"27","author":"Lazar","year":"2021","unstructured":"Lazar et al. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study. Clin. Microbiol Infect. 27, 1037.e1\u2013e8 (2021).","journal-title":"Clin. Microbiol Infect."},{"key":"4605_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fmolb.2020.594497","volume":"7","author":"SY Kim","year":"2020","unstructured":"Kim, S. Y., Zhang, F., Harris, D. A. & Linhardt, R. J. Structural features of heparin and its interactions with cellular prion protein measured by surface plasmon resonance. Front Mol. Biosci. 7, 59\u201364 (2020).","journal-title":"Front Mol. Biosci."},{"key":"4605_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fimmu.2023.1178135","volume":"14","author":"M Paulsson","year":"2023","unstructured":"Paulsson, M. et al. TLR4-mediated release of heparin-binding protein in human airways: a co-stimulatory role for IL-26. Front. Immunol. 14, 11\u201337 (2023).","journal-title":"Front. Immunol."},{"key":"4605_CR28","doi-asserted-by":"publisher","first-page":"e1009054","DOI":"10.1371\/journal.ppat.1009054","volume":"16","author":"KR Eichelberger","year":"2020","unstructured":"Eichelberger, K. R. & Goldman, W. E. Manipulating neutrophil degranulation as a bacterial virulence strategy. PLoS Pathog. 16, e1009054 (2020).","journal-title":"PLoS Pathog."},{"key":"4605_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/vaccines9091038","volume":"9","author":"R Chatterjee","year":"2021","unstructured":"Chatterjee, R. et al. Development of a conserved chimeric vaccine for induction of strong immune response against Staphylococcus aureus using immunoinformatics approaches. Vaccines 9, 40\u201350 (2021).","journal-title":"Vaccines"},{"key":"4605_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/cc11353","volume":"16","author":"A Linder","year":"2012","unstructured":"Linder, A. et al. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis. Crit. Care 16, R90 (2012).","journal-title":"Crit. Care"},{"key":"4605_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2820-z","volume":"24","author":"J Tverring","year":"2020","unstructured":"Tverring, J. et al. Heparin-binding protein kinetics in septic shock. Crit. Care 24, 93 (2020).","journal-title":"Crit. Care"},{"key":"4605_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078687","volume":"14","author":"L Zuo","year":"2024","unstructured":"Zuo, L. et al. Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China. BMJ Open 14, e078697 (2024).","journal-title":"BMJ Open"},{"key":"4605_CR33","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1111\/febs.15803","volume":"289","author":"A Othman","year":"2022","unstructured":"Othman, A., Sekheri, M. & Filep, J. G. Roles of neutrophil granule proteins in orchestrating inflammation and immunity. FEBS J. 289, 3932\u20133953 (2022).","journal-title":"FEBS J."},{"key":"4605_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703515","volume":"12","author":"CM Feng","year":"2021","unstructured":"Feng, C. M. et al. Associations of serum resistin with the severity and prognosis in patients with community-acquired pneumonia. Front. Immunol. 12, 703515 (2021).","journal-title":"Front. Immunol."},{"key":"4605_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01588-21","volume":"9","author":"S Tamiya","year":"2021","unstructured":"Tamiya, S. et al. Neutrophil-mediated lung injury both via TLR2-dependent production of IL-1\u03b1 and IL-12p40, and TLR2-independent CARDS toxin after Mycoplasma pneumoniae infection in mice. Microbiol. Spectr. 9, e0158821 (2021).","journal-title":"Microbiol. Spectr."},{"key":"4605_CR36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1019","volume":"138","author":"DJ Williams","year":"2016","unstructured":"Williams, D. J. et al. Predicting severe pneumonia outcomes in children. Pediatrics 138, e20161019 (2016).","journal-title":"Pediatrics"},{"key":"4605_CR37","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.3390\/ijms21145032","volume":"21","author":"DH Choi","year":"2020","unstructured":"Choi, D. H. et al. A synthetic cell-penetrating heparin-binding peptide derived from BMP4 with anti-inflammatory and chondrogenic functions for the treatment of arthritis. Int. J. Mol. Sci. 21, 5032 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"4605_CR38","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/587658","volume":"46","author":"P Katona","year":"2008","unstructured":"Katona, P. & Katona-Apte, J. The interaction between nutrition and infection. Clin. Infect. Dis. 46, 1582\u20131588 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"4605_CR39","doi-asserted-by":"publisher","first-page":"460S","DOI":"10.1093\/ajcn\/66.2.460S","volume":"66","author":"RK Chandra","year":"1997","unstructured":"Chandra, R. K. Nutrition and the immune system: an introduction. Am. J. Clin. Nutr. 66, 460S\u2013463S (1997).","journal-title":"Am. J. Clin. Nutr."},{"key":"4605_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08463-x","volume":"23","author":"K Hanevik","year":"2023","unstructured":"Hanevik, K. et al. Heparin-binding protein as a predictor of mortality in Ugandan children with severe infections. BMC Infect. Dis. 23, 497 (2023).","journal-title":"BMC Infect. Dis."},{"key":"4605_CR41","doi-asserted-by":"publisher","first-page":"7314","DOI":"10.12998\/wjcc.v10.i21.7314","volume":"10","author":"BY Niu","year":"2022","unstructured":"Niu, B. Y., Wang, G., Li, B., Zhen, G. S. & Weng, Y. B. Sequential treatment of severe pneumonia with respiratory failure and its influence on respiratory mechanical parameters and hemodynamics. World J. Clin. Cases 10, 7314\u20137323 (2022).","journal-title":"World J. Clin. Cases"},{"key":"4605_CR42","doi-asserted-by":"publisher","first-page":"e30010","DOI":"10.1097\/MD.0000000000030010","volume":"101","author":"A Bashir","year":"2022","unstructured":"Bashir, A., Khan, R., Thompson, S. & Caceres, M. A retrospective observational study of biomarker levels and severity assessment in pediatric community-acquired pneumonia. Medcines 101, e30010 (2022).","journal-title":"Medcines"},{"key":"4605_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/jeccm.2019.11.03","volume":"4","author":"SW Loh","year":"2020","unstructured":"Loh, S. W. et al. Burden of respiratory support differs between critically ill children with severe bacterial and viral pneumonia. J. Emerg. Crit. Care Med. 4, 1\u20138 (2020).","journal-title":"J. Emerg. Crit. Care Med."},{"key":"4605_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1183\/09031936.00128107","volume":"32","author":"C Garcia-Vidal","year":"2008","unstructured":"Garcia-Vidal, C. et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur. Respir. J. 32, 733\u2013739 (2008).","journal-title":"Eur. Respir. J."},{"key":"4605_CR45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archinte.162.9.1059","volume":"162","author":"EM Mortensen","year":"2002","unstructured":"Mortensen, E. M. et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch. Intern Med 162, 1059\u20131065 (2002).","journal-title":"Arch. Intern Med"},{"key":"4605_CR46","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1590\/S1807-59322010001100005","volume":"65","author":"GA Costa","year":"2010","unstructured":"Costa, G. A., Delgado, A. F., Ferraro, A. & Okay, T. S. Application of the pediatric risk of mortality (PRISM) score and determination of mortality risk factors in a tertiary pediatric intensive care unit. Clinics 65, 1087\u20131092 (2010).","journal-title":"Clinics"},{"key":"4605_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43054-023-00170-1","volume":"71","author":"A Abd El Megied","year":"2023","unstructured":"Abd El Megied, A., Mohamed, A. F. A. M., Aziz, M. M. & Ebrahim, M. M. Diagnostic and predictive value of Respiratory Index of Severity in Children (RISC) scoring system in community-acquired pneumonia: a prospective cross-sectional study. Egypt Pediatr. Assoc. Gaz. 71, 24 (2023).","journal-title":"Egypt Pediatr. Assoc. Gaz."},{"key":"4605_CR48","doi-asserted-by":"publisher","first-page":"967211","DOI":"10.3389\/fped.2022.767690","volume":"10","author":"F Lu","year":"2022","unstructured":"Lu, F., Qin, H. & Li, A.-M. The correlation between mechanical ventilation duration, pediatric sequential organ failure assessment score, and blood lactate level in children in pediatric intensive care. Front. Pediatr. 10, 967211 (2022).","journal-title":"Front. Pediatr."},{"key":"4605_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08762-3","volume":"23","author":"X Xiao","year":"2023","unstructured":"Xiao, X., Hong, Y., Wang, S., Ma, M. & Xu, Z. Diagnostic value of plasma heparin-binding protein and the heparin-binding protein-to-albumin ratio in patients with community-acquired pneumonia: a retrospective study. BMC Infect. Dis. 23, 777 (2023).","journal-title":"BMC Infect. Dis."},{"key":"4605_CR50","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston, N. R. & Ashworth, J. J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754 (2018).","journal-title":"Front. Immunol."},{"key":"4605_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.12775\/JEHS.2021.11.11.015","volume":"11","author":"V Dudnyk","year":"2021","unstructured":"Dudnyk, V. & Pasik, V. Liver dysfunction in children with community-acquired pneumonia: the role of infectious and inflammatory markers. J. Educ. Health Sport 11, 169\u2013181 (2021).","journal-title":"J. Educ. Health Sport"},{"key":"4605_CR52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000314853","volume":"2","author":"A Linder","year":"2010","unstructured":"Linder, A., Soehnlein, O. & Akesson, P. Roles of heparin-binding protein in bacterial infections. J. Innate Immun. 2, 431\u2013438 (2010).","journal-title":"J. Innate Immun."},{"key":"4605_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cca.2022.11.028","volume":"539","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. Heparin-binding protein as a biomarker of severe sepsis in the pediatric intensive care unit: a multicenter, prospective study. Clin. Chim. Acta 539, 26\u201333 (2023).","journal-title":"Clin. Chim. Acta"},{"key":"4605_CR54","doi-asserted-by":"publisher","first-page":"ofae030","DOI":"10.1093\/ofid\/ofae386","volume":"11","author":"H Mishra","year":"2024","unstructured":"Mishra, H. et al. Heparin-binding protein stratifies mortality risk among Ugandan children hospitalized with respiratory distress. Open Forum Infect. Dis. 11, ofae030 (2024).","journal-title":"Open Forum Infect. Dis."},{"key":"4605_CR55","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2147\/IJGM.S409328","volume":"16","author":"J Tang","year":"2023","unstructured":"Tang, J., Yuan, H., Wu, Y. L., Fu, S. & Pan, X. Y. The predictive value of heparin-binding protein and D-dimer in patients with sepsis. Int. J. Gen. Med. 16, 2295\u20132303 (2023).","journal-title":"Int. J. Gen. Med."},{"key":"4605_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-020-00338-8","volume":"8","author":"J Tverring","year":"2020","unstructured":"Tverring, J. et al. Repeated measures of heparin-binding protein (HBP) and procalcitonin during septic shock: biomarker kinetics and association with cardiovascular organ dysfunction. Intensive Care Med. Exp. 8, 51 (2020).","journal-title":"Intensive Care Med. Exp."},{"key":"4605_CR57","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s13312-021-2372-6","volume":"58","author":"K Pillai","year":"2021","unstructured":"Pillai, K., Sartho, E. R., Lakshmi, T. & Parvathy, V. Diagnosis and assessment of severity of pediatric pneumonia using the respiratory index of severity (RISC) scoring system. Indian Pediatr. 58, 1052\u20131055 (2021).","journal-title":"Indian Pediatr."},{"key":"4605_CR58","first-page":"277","volume":"92","author":"GM El-Mashad","year":"2020","unstructured":"El-Mashad, G. M., El-Mekkawy, M. S. & Zayan, M. H. Paediatric sequential organ failure assessment (pSOFA) score: a new mortality prediction score in the paediatric intensive care unit. Pediatrics (Engl. Ed). 92, 277\u2013285 (2020).","journal-title":"Pediatrics (Engl. Ed)."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04605-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04605-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04605-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:04:54Z","timestamp":1787925894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04605-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4605"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04605-w","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation 2 has been corrected to 'Clinical Pathology Department, Faculty of Medicine, Menoufia University, Shebin El-kom, Egypt.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was reviewed and approved by the Research Ethics Committee of the Faculty of Medicine, Menoufia University (Approval Number: 6\/2024PEDI8). Written informed consent was obtained freely from the parents or legal guardians of all participants after they were fully informed about the objectives and procedures of the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from the parents (or legal representative).","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}